Stay updated on Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.

Latest updates to the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for the carfilzomib, pomalidomide, and dexamethasone study is displayed, with details on its completed status, study design, participant criteria, locations, and measured outcomes.SummaryDifference64%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2 while the page remains a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe study record page now displays a 403 Forbidden message, replacing the previously visible study details and related sections. This change blocks access to essential information about the trial on that page.SummaryDifference21%

Stay in the know with updates to Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.